Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.

Description

DynaMedex merges the clinical acumen and meticulously curated disease information from DynaMed with the thorough overview of treatment options, expansive drug data, and AI-driven search functionalities of Micromedex. It equips users with evidence-based insights that facilitate superior clinical decision-making and enhance patient outcomes. Clinicians utilizing DynaMedex can effortlessly search, browse, and stay updated on the topics and specialties that are most relevant to their practice, receiving both quick responses and comprehensive insights into their drug inquiries. Delve into this innovative tool and discover how it fosters improved clinical decision-making. Users can swiftly obtain answers to their drug-related questions through intuitive and conversational search features. The "Ask Watson" assistant employs artificial intelligence to streamline access to drug information, eliminating the need for traditional keyword searches in favor of natural language queries, allowing users to communicate in their own words and receive the information they seek efficiently. This seamless integration of AI technology not only saves time but also empowers healthcare professionals to make informed decisions with greater ease.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

Free
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Artrya

Country

Australia

Website

www.artrya.com

Vendor Details

Company Name

EBSCO

Country

United States

Website

www.ebsco.com/clinical-decisions/dynamed-solutions/dynamedex

Product Features

Product Features

Alternatives

Alternatives

DynaMed Reviews

DynaMed

EBSCO
Micromedex Reviews

Micromedex

Merative
75health Reviews

75health

Kaaspro